CLASS I Device recall · Reported 15 Aug 2018 · FDA Enforcement Report
AmniSure ROM Test under the following labels recalled by Qiagen Sciences
Qiagen Sciences is recalling AmniSure ROM Test under the following labels, distributed nationwide in the US. The recall was initiated on 18 May 2018 and the FDA has classified it as Class I.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-2577-2018
- FDA event ID
- 80404
- Recalling firm
- Qiagen Sciences, Germantown, MD
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- 18 May 2018
- FDA classified
- 8 Aug 2018
- Reported
- 15 Aug 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Device type
- Test Kits & Diagnostics
Timeline
| 18 May 2018 | Recall initiated by company | |
| 8 Aug 2018 | Classified by FDA | +82 days |
| 15 Aug 2018 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Potential for control line not appearing on the test strip
Product as listed by the FDA
AmniSure ROM Test under the following labels: 1) Catalog Number FMRT-1-25 and 2) Catalog Number FMRT-1-25-CA Product Usage: Rapid, non-instrumented, qualitative immunochromatographic test for the in vitro detection of amniotic fluid in vaginal discharge of pregnant women.
Where it was distributed
Worldwide - US Nationwide distribution an in the country of , Canada
Questions about this recall
Why was it recalled?
Potential for control line not appearing on the test strip
Which lots are affected?
1) UDI 14053228022319; Lot Numbers - 557016546, 557016547 & 5600115, Exp Date 7/28/2020 2) UDI 14053228022333; Lot Number - 557016409, Exp Date 7/28/2020
Where was it sold?
Worldwide - US Nationwide distribution an in the country of , Canada
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Qiagen Sciences
All 23| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | QIAstat-Dx Respiratory Panel Plus Reference Number recalled | Qiagen Sciences | Device Malfunction | 12 states |
| Device | CLASS II | QIAcube Connect MDx - IVD Instrument designed to perform recalled | Qiagen Sciences | Potency & Assay | Nationwide |
| Device | CLASS II | EZ2 Connect MDx-IVD Designed to perform automated isolation recalled | Qiagen Sciences | Temperature Abuse | Nationwide |
| Device | CLASS II | QIAstat-Dx Respiratory Sars-CoV-2 Panel multiplexed nucleic recalled | Qiagen Sciences | Other | Nationwide |
| Device | CLASS II | QIAcube Connect MDx recalled by Qiagen Sciences | Qiagen Sciences | Other | 26 states |
Other Test Kits & Diagnostics recalls
All 2,675| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Nextseq 550Dx Instrument recalled by Illumina | Illumina | Other | Nationwide |
| Device | CLASS II | NovaSeq 6000Dx Instrument recalled by Illumina | Illumina | Other | Nationwide |
| Device | CLASS II | Liaison Plex Gram-Negative Blood Culture Assay recalled by Luminex | Luminex | Potency & Assay | Nationwide |
| Device | CLASS II | MiSeq Dx Instrument recalled by Illumina | Illumina | Other | Nationwide |
| Device | CLASS II | Techno-Path Multichem AE Unassayed Level recalled | Techno-path Manufacturing | Potency & Assay | Nationwide |